Masimo

Masimo Gross Profit

Delisted

The Gross Profit of Masimo (MASI) as of Nov 22, 2026 is 945.20 M USD. In the previous year, Gross Profit was 1.00 B USD — a change of -5.89% (lower).

Gross Profit

945.20 MUSD

YoY

-5.89%

Last updated:

Gross Profit of Masimo is 2025 945.20 M USD. Gross Profit of Masimo was 2024 1.00 B USD. It decreases by -5.89% lower compared to the previous year.

The Masimo Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2018
574.89 M USD
Jan 1, 2019
629.17 M USD
Jan 1, 2020
743.00 M USD
Jan 1, 2021
808.40 M USD
Jan 1, 2022
1.06 B USD
Jan 1, 2023
1.00 B USD
Jan 1, 2024
1.00 B USD
Jan 1, 2025
945.20 M USD
The Masimo Gross Profit history
YEARGross ProfitYoY
945.20 MUSD-5.89%
1.00 BUSD+0.09%
1.00 BUSD-5.22%
1.06 BUSD+30.97%
808.40 MUSD+8.80%
743.00 MUSD+18.09%
629.17 MUSD+9.44%
574.89 MUSD+10.13%
522.03 MUSD+9.13%
478.34 MUSD+16.67%
409.98 MUSD+4.91%
390.78 MUSD+8.90%
358.83 MUSD+9.98%
326.25 MUSD+10.92%
294.13 MUSD+2.99%
285.58 MUSD+14.78%
248.80 MUSD+14.33%
217.62 MUSD+19.13%
182.68 MUSD+12.28%
162.70 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Masimo Revenue

Masimo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
2.04 B USD
210.00 M USD
143.50 M USD
Jan 1, 2023
2.05 B USD
138.40 M USD
81.50 M USD
Jan 1, 2024
2.09 B USD
-261.70 M USD
-304.90 M USD
Jan 1, 2025
1.53 B USD
312.80 M USD
-151.50 M USD
Jan 1, 2026 (e)
1.63 B USD
498.99 M USD
323.74 M USD
Jan 1, 2027 (e)
1.75 B USD
557.22 M USD
358.94 M USD
Jan 1, 2028 (e)
1.89 B USD
617.50 M USD
398.32 M USD
Jan 1, 2029 (e)
1.97 B USD
617.25 M USD
398.25 M USD

Masimo Margins

Masimo stock margins

The Masimo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Masimo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Masimo.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
52.01 %
10.32 %
7.05 %
Jan 1, 2023
49.00 %
6.76 %
3.98 %
Jan 1, 2024
47.96 %
-12.50 %
-14.56 %
Jan 1, 2025
61.90 %
20.49 %
-9.92 %
Jan 1, 2026 (e)
61.90 %
30.56 %
19.83 %
Jan 1, 2027 (e)
61.90 %
31.86 %
20.53 %
Jan 1, 2028 (e)
61.90 %
32.71 %
21.10 %
Jan 1, 2029 (e)
61.90 %
31.26 %
20.17 %

Masimo Stock analysis

What does Masimo do? Masimo Corporation is an American medical technology company based in Irvine, California. The company was founded in 1989 by Professor Joe Kiani, who is still the chairman and CEO of the company today. With innovative products and advanced technology, Masimo aims to optimize medical diagnostic and treatment procedures to improve patient care. The business model of Masimo Corp focuses on developing and marketing products and solutions for patient monitoring and treatment in hospitals, intensive care facilities, and outpatient clinics. The company relies on high levels of innovation and collaboration with physicians, scientists, and other experts. The goal is to improve existing medical procedures, explore new applications for the technology, and optimize patient care. Masimo Corp's products are divided into different divisions that focus on various aspects of medical care. One example is the "Patient Monitoring" division, which offers various monitoring systems for vital signs such as respiration, pulse, and oxygen saturation. This includes products like the Rad-67 pulse oximeter or the Root patient monitor, which continuously monitor patients during treatment to enhance safety and effectiveness. Another division is "Anesthesia and Sedation," which focuses on solutions for anesthesiologists and intensive care specialists. Masimo Corp offers products such as the SedLine brain monitor or the EMMA main gas monitor, which enable physicians to control anesthesia depth more precisely and reduce the risk of complications. In addition to patient monitoring systems, Masimo Corp also provides solutions for neonatal care. The "Neonatal Care" division includes products like the Masimo Radical-7 pulse oximeter for monitoring premature infants or the Pronto-7 pulse oximeter for fast and accurate monitoring of newborns in the delivery room. Furthermore, Masimo Corp has developed products for monitoring surgical patients. The "Surgical and Minimally Invasive Monitoring" division, for example, offers the MOC-9 monitoring system for precise monitoring of hemodynamics during surgery. A unique product of Masimo Corp is also the Masimo SET sensor, which provides more accurate and reliable measurement of blood oxygen saturation than traditional pulse oximeter sensors. The company has filed over 100 patents worldwide for this technology and has been recognized with numerous awards and accolades. In summary, Masimo Corp is an innovative company specializing in improving medical care through the development and marketing of products for patient monitoring and treatment. With its state-of-the-art technologies and collaboration with experts in medical research, Masimo Corp sets standards for patient safety and treatment effectiveness. Masimo is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Masimo stock

Gross Profit of Masimo is 945.20 M USD in 2025.

Gross Profit of Masimo changed from 1.00 B USD to 945.20 M USD, representing a -5.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Masimo since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Masimo historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Masimo

All Key Metrics — Masimo